Dermatology Clinical Trials

and/or
36 Clinical Trials found
A Phase 2/3 Study of IDE196 (Darovasertib) and Crizotinib Compared to Standard Treatment in Uveal Melanoma
A Phase 3 Study Assessing the Addition of Cetuximab to Standard Pembrolizumab Immunotherapy for Head and Neck Cancer
A Phase 3 Study Comparing IMA203 With Standard Therapy in People with Advanced Melanoma
A Phase 3 Study Comparing Naporafenib and Trametinib to Standard Treatment in People With Melanoma of the Skin
A Phase 3 Study of Ivonescimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy as Initial Treatment for Advanced Lung Cancer
A Phase I/IIA Study of LNS8801 with and without Pembrolizumab Immunotherapy in People with Advanced Melanoma
A Phase II Study of Axitinib/Nivolumab Alone and with Ipilimumab or Radiation Therapy to Treat Previously Untreated Advanced Mucosal Melanoma
A Phase II Study of Nivolumab Immunotherapy Alone and with Cabozantinib to Prevent Mucosal Melanoma Relapse after Surgery
A Phase II Study of ZEN003694 in People with Advanced Squamous Cell Lung Cancer
A Pilot Study of LN-144 Immunotherapy in People with Metastatic Uveal Melanoma